Bevacizumab and Atezolizumab With or Without Cobimetinib in Treating Patients With Untreated Melanoma Brain Metastases

Clinical trial NCT03175432 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03175432
Sponsor: M.D. Anderson Cancer Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

BRAF V600 Wild Type Clinical Stage IV Cutaneous Melanoma AJCC v8 Intracranial Melanoma Metastatic Malignant Neoplasm in the Brain Metastatic Melanoma Pathologic Stage IV Cutaneous Melanoma AJCC v8 Refractory Melanoma

Start date: 2017-06-15
Primary completion: 2028-06-30
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.